SOUVENIR & ABSTRACT BOOK
International Conference on Medicinal Plants: Resource for Affordable New Generation Healthcare March 20-22, 2015 Organized by CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow-226015, India CSIR-CIMAP
With the Support of
NMPB
MBDA
NABARD
SBI
Herbal/ botanical origin and considered products may contain ingredients from botanical origin. USP since long time had products from herbal origin. Most famous products like ENO/ Gasofast/ Vicks/ Balms/ Ispaghula/ Glucosamine, liver tonics, digestives, bone tonics, health supplements are of from herbal origin only. Guidelines are drafted by WHO/ CDSCO/ USP/ FSSAI which is more focusing on Herbal Medicines, Herbal/ Botanical Supplements, Herbal Dietary Supplement, Medical Food etc.
O–30: Prospects of public private partnership (PPP) for production of medicinal plants in India Anil Kumar Singh*, Sanjay Kumar, Ram Suresh, R.P. Bansal and V.K.S. Tomar Technology and Business Development (TBD) Department, CSIR-Central institute of Medicinal and Aromatic Plants, Lucknow-226015, India *Consultant, CSIR-CIMAP Email:
[email protected]
Various R&D institutions, government departments and promotional agencies including universities, industries, NGOs etc. are currently promoting the cultivation of medicinal plants among the farmers. However, quite often the farmers face the difficulty in arranging the required inputs for cultivation and later on, in marketing of their produce. In order to boost the extension of the area under various economically important medicinal plants required by the industry, it is envisaged to develop farmer, industry and R&D linkage. Such linkage, wherever established, may lead to the quality production and marketing besides ensuring optimum utilization of the available resources that can help in economic gains to the farmers and also meet the demand of the industry. On the other hand R&D institutions may also benefit in terms of regular feedback about the performance of the improved plant varieties and technologies developed and disseminated by them. The model of the linkage among farmers, industry and R&D institution involves knowhow transfer to the farmers by the research institutes through hands on training, demonstration and regular guidance till they successfully grow, harvest and sell the produce. They are provided with the quality planting material and technical literature and encouraged to grow the selected crop after forming a cluster at the village level. The farmers are apprised about the necessary steps and precautions required for raising nursery, planting, agricultural operations including control of insects and pests, harvesting, processing and the quality aspects. The current status and future prospects of the public private partnership with special reference to the cultivation and utilization of some economically important medicinal crops would be discussed in this presentation with appropriate models and case studies.
O–31: Introduction of CSIR-CIMAP improved varieties and promotion of cultivation of Ashwagandha (Withania somnifera) for improving the economy of small and marginal farmers in semi arid tropical (SAT) regions of Deccan plateau Ashish Kumar, D.K. Rajput, K.Y. Dayal, S. Nagaraju and Pandu Sastry Kakaraparthi CSIR-Central Institute of Medicinal and Aromatic Plants, Research Centre, Boduppal, Hyderabad-500092, India Email:
[email protected]
Withania somnifera [Family: Solanaceae] commonly known as ‘ashwagandha’ is one of the most important medicinal plants used in various traditional systems of medicine in India. In Andhra Pradesh, Anantapur district is the largest district and it is one of the driest parts of the country with second lowest average rainfall of 520.4 mm and aridity index of 72.5%. Groundnut is the major crop of this region and problems in groundnut cultivation started in the late nineties when the oil market was deregulated and the farmers were left high and dry in the light of import of palm oil. The search for alternative crops to replace groundnut led the farmers to CSIR-CIMAP and based on the information provided by the CIMAP Research Centre, Hyderabad, the farmers started pilot scale cultivation of aswagandha during 2005-06. CSIR-CIMAP started propagating CSIR-CIMAP varieties from 2007 onwards. The economic advantage of CSIR-CIMAP varieties was demonstrated in farmer’s fields. Quality seed of the improved varieties were multiplied and supplied at subsidised rates; market linkages were established and CIMAP promoted the cultivation in the SAT areas of Andhra Pradesh. Cultivation of CSIR-CIMAP variety
18
helped the small and marginal farmers economically and the area under cultivation reached 10,000 acres leading to a production of 1500 tons of dry root and 750 tons of seed between 2007 and 2014. With this production level farmers today started earning a profit of Rs. 25,000 - 35,000/acre which is several times more than they get from traditional crops like groundnut or bengalgram. Details of this cultivation model for W. somnifera will be presented in the meeting.
O–32: Importance of medicinal and aromatic plants in Egypt Mahassen M.A. Sidky Horticulture Research Institute, Agricultural Research Centre, 24, Amin-El-Raffy Street, Dokky, Giza, Egypt Email:
[email protected]
Egypt has a rich history in the production and trade of medicinal plants. Chamomile, peppermint, spearmint, fennel, coriander, cumin, marjoram, basil are the most important cultivated plants in addition to more than 350 wild plants that have medicinal importance. Export of medicinal and aromatic plants (MAPs) comes in the fifth rank of the Egyptian agricultural exportation. About 90% of such important crops are produced for the export market, and mainly in Upper Egypt. Egypt exports about 50,000 tons of MAPs, annually, to the United States, followed by the European Union. These crops represent good cash return to small farmers. The gathering and cultivation of MAPs provide critical sources of cash income to many rural communities, especially, women, landless poor and marginalized farmers. This paper will represent in details the biodiversity, conservation, cultivation, marketing and suggested recommendations to overcome the current constrains.
O–33: Strategies to modulate terpenoid indole alkaloid pathway in Vinca minor Priyanka Verma and Ajay K. Mathur CSIR-Central Institute of Medicinal and Aromatic Plants, P.O. CIMAP, Lucknow-226015, India Email:
[email protected]
Vinca minor (Family: Apocynaceae), commonly known as “Lesser or Dwarf periwinkle”, is a perennial herb valued for its > 40 different types of terpenoid indole alkaloids (TIAs) with strong astringent, wound-healing, antidermatosic, antigalactic, cognitive and nootropic activities. Among others, the alkaloid vincamine used as cerebral stimulant and vasodilators in the treatment of arteriosclerosis and dementia. All TIAs are synthesised from a common precursor–strictosidine–that is a condensation product of tryptophan-derived indole moiety tryptamine and geraniol-derived terpenoid moiety secologenin. Four different strategies of biotic elicitation, abiotic elicitation with cyclogenase inhibition, overexpression of pathway genes and transgenic plant production were employed to hairy roots and cell suspensions of V. minor to increase the flux towards vincamine biosynthesis. Hydroxylase/acetyltransferase elicitors and cyclooxygenase inhibitor along with various precursors from primary shikimate and secoiridoid pools have been fortified to vincamine less hairy root clone of V. minor to determine the regulatory factors associated with vincamine biosynthesis. Second strategy was associated with biotic elicitation, where a vincamine positive hairy root clone of V. minor and its subsequently raised cell suspensions were treated with culture filtrate of four endophytic fungi namely Chaetomium globosum; Aspergillus niveoglaucus; Paecilomyces lilacinus and Trichoderma harzianum. In the third strategy Tryptophan decarboxylase (TDC) and strictosidine synthase (STR) genes from Catharanthus roseus have been successfully over-expressed in the rol gene integrated cell suspensions. Last strategy was dealing with transgenic plant production in V. minor and its various assessments. Enhanced TIA flux and vincamine content will be discussed during the presentation.
19
Lucknow-226015, India Ph.: +91-522-2718634, 2718590; Fax: +91-522-2719072 Email:
[email protected]; Website: www.cimap.res.in
www.armyprintingpress.com Lucknow (0522) 6565333
CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP),
army printing press
CSIR-CIMAP
